Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds AKABY.
No tracked institution reports a position in AKABY as of their last filing.
No one on the platform has traded AKABY yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| AKABYALK-Abelló A/S | $90.00 | +0.00% | $0 | — |
| ABCZFAbcam plc | $22.25 | +0.68% | $5.1B | — |
| ALPNAlpine Immune Sciences, Inc. | $64.97 | +0.02% | $4.5B | — |
| ARNAArena Pharmaceuticals, Inc. | $99.99 | +0.00% | $0 | — |
| CCXIChurchill Capital Corp XI | $16.03 | -0.99% | $672M | — |
| GBTGlobal Blood Therapeutics, Inc. | $68.49 | +0.01% | $0 | — |
| ISEEIVERIC bio, Inc. | $39.95 | +0.38% | $5.5B | — |
Source: Financial Modeling Prep · peers by sector/industry